Search

everythinglearnresearchcommunity

for

Search:↓

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The article concludes that better understanding gene regulation related to seasonal changes can offer insights into the mechanisms of seasonal timing in mammals.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

No cure for female pattern hair loss, but various effective treatments exist.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

High doses of finasteride cause cell growth and tumors in mice.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.